74 related articles for article (PubMed ID: 14985278)
1. Daptomycin activity and spectrum: a worldwide sample of 6737 clinical Gram-positive organisms.
Streit JM; Jones RN; Sader HS
J Antimicrob Chemother; 2004 Apr; 53(4):669-74. PubMed ID: 14985278
[TBL] [Abstract][Full Text] [Related]
2. Daptomycin avoids drug resistance mediated by the BceAB transporter in
Faure A; Manuse S; Gonin M; Grangeasse C; Jault J-M; Orelle C
Microbiol Spectr; 2024 Feb; 12(2):e0363823. PubMed ID: 38214521
[TBL] [Abstract][Full Text] [Related]
3. Antibiotics and Carbohydrate-Containing Drugs Targeting Bacterial Cell Envelopes: An Overview.
Riu F; Ruda A; Ibba R; Sestito S; Lupinu I; Piras S; Widmalm G; Carta A
Pharmaceuticals (Basel); 2022 Jul; 15(8):. PubMed ID: 36015090
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the Rapid Emergence of Daptomycin Resistance in
Mitchell KF; McElvania E; Wallace MA; Droske LE; Robertson AE; Westblade LF; Burnham CA
J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33472898
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical Characterization of Daptomycin Interaction with Negatively Charged Lipid Membranes.
Juhaniewicz-Dębińska J; Dziubak D; Sęk S
Langmuir; 2020 May; 36(19):5324-5335. PubMed ID: 32340456
[TBL] [Abstract][Full Text] [Related]
6. Optimizing the Dosing Regimens of Daptomycin Based on the Susceptible Dose-Dependent Breakpoint against Vancomycin-Resistant Enterococci Infection.
Santimaleeworagun W; Changpradub D; Thunyaharn S; Hemapanpairoa J
Antibiotics (Basel); 2019 Nov; 8(4):. PubMed ID: 31795437
[TBL] [Abstract][Full Text] [Related]
7.
Rezaei Bookani K; Marcus R; Cheikh E; Parish M; Salahuddin U
IDCases; 2018; 11():26-30. PubMed ID: 29619320
[TBL] [Abstract][Full Text] [Related]
8. In Silico Discovery of Novel Ligands for Antimicrobial Lipopeptides for Computer-Aided Drug Design.
Jujjavarapu SE; Dhagat S
Probiotics Antimicrob Proteins; 2018 Jun; 10(2):129-141. PubMed ID: 29218506
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial and Antibiofilm Activities of a Novel Synthetic Cyclic Lipopeptide against Cariogenic Streptococcus mutans UA159.
Min KR; Galvis A; Williams B; Rayala R; Cudic P; Ajdic D
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533236
[TBL] [Abstract][Full Text] [Related]
10. Bloodstream infections in the Intensive Care Unit.
Bassetti M; Righi E; Carnelutti A
Virulence; 2016 Apr; 7(3):267-79. PubMed ID: 26760527
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of daptomycin in combination with β-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci.
Hindler JA; Wong-Beringer A; Charlton CL; Miller SA; Kelesidis T; Carvalho M; Sakoulas G; Nonejuie P; Pogliano J; Nizet V; Humphries R
Antimicrob Agents Chemother; 2015 Jul; 59(7):4279-88. PubMed ID: 25963982
[TBL] [Abstract][Full Text] [Related]
12. Organic extracts from Indigofera suffruticosa leaves have antimicrobial and synergic actions with erythromycin against Staphylococcus aureus.
Bezerra Dos Santos AT; Araújo TF; Nascimento da Silva LC; da Silva CB; de Oliveira AF; Araújo JM; Correia MT; Lima VL
Front Microbiol; 2015; 6():13. PubMed ID: 25699022
[TBL] [Abstract][Full Text] [Related]
13. A current perspective on daptomycin for the clinical microbiologist.
Humphries RM; Pollett S; Sakoulas G
Clin Microbiol Rev; 2013 Oct; 26(4):759-80. PubMed ID: 24092854
[TBL] [Abstract][Full Text] [Related]
14. Enterococcal endocarditis: can we win the war?
Munita JM; Arias CA; Murray BE
Curr Infect Dis Rep; 2012 Aug; 14(4):339-49. PubMed ID: 22661339
[TBL] [Abstract][Full Text] [Related]
15. Acute generalized exanthematous pustulosis caused by daptomycin.
Leng TY; Aan MK; Chan M; Tsien LT
Ann Dermatol; 2011 Dec; 23(Suppl 3):S288-9. PubMed ID: 22346259
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of the lipopeptide antibiotic daptomycin by hydrolytic mechanisms.
D'Costa VM; Mukhtar TA; Patel T; Koteva K; Waglechner N; Hughes DW; Wright GD; De Pascale G
Antimicrob Agents Chemother; 2012 Feb; 56(2):757-64. PubMed ID: 22083474
[TBL] [Abstract][Full Text] [Related]
17. Diabetic foot infections: microbiological aspects, current and future antibiotic therapy focusing on methicillin-resistant Staphylococcus aureus.
Ambrosch A; Haefner S; Jude E; Lobmann R
Int Wound J; 2011 Dec; 8(6):567-77. PubMed ID: 21883937
[TBL] [Abstract][Full Text] [Related]
18. Complicated skin and soft tissue infections: literature review of evidence for and experience with daptomycin.
White B; Seaton RA
Infect Drug Resist; 2011; 4():115-27. PubMed ID: 21753891
[TBL] [Abstract][Full Text] [Related]
19. A guide to antibiotics for the interventional radiologist.
Zarrinpar A; Kerlan RK
Semin Intervent Radiol; 2005 Jun; 22(2):69-79. PubMed ID: 21326676
[TBL] [Abstract][Full Text] [Related]
20. Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians.
Kelesidis T; Humphries R; Uslan DZ; Pegues DA
Clin Infect Dis; 2011 Jan; 52(2):228-34. PubMed ID: 21288849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
